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Purpose: We investigated the changes in physiological and performance parameters
after a Live High-Train Low (LHTL) altitude camp in normobaric (NH) or hypobaric
hypoxia (HH) to reproduce the actual training practices of endurance athletes using a
crossover-designed study.
Methods: Well-trained triathletes (n = 16) were split into two groups and completed
two 18-day LTHL camps during which they trained at 1100–1200m and lived at 2250m
(PiO2 = 111.9 ± 0.6 vs. 111.6 ± 0.6mmHg) under NH (hypoxic chamber; FiO2 18.05
± 0.03%) or HH (real altitude; barometric pressure 580.2 ± 2.9mmHg) conditions. The
subjects completed the NH and HH camps with a 1-year washout period. Measurements
and protocol were identical for both phases of the crossover study. Oxygen saturation
(SpO2) was constantly recorded nightly. PiO2 and training loads were matched daily.
Blood samples and VO2max were measured before (Pre-) and 1 day after (Post-1) LHTL.
A 3-km running-test was performed near sea level before and 1, 7, and 21 days after
training camps.
Results: Total hypoxic exposure was lower for NH than for HH during LHTL (230 vs.
310 h; P < 0.001). Nocturnal SpO2 was higher in NH than in HH (92.4 ± 1.2 vs. 91.3 ±
1.0%, P < 0.001). VO2max increased to the same extent for NH and HH (4.9 ± 5.6 vs.
3.2 ± 5.1%). No difference was found in hematological parameters. The 3-km run time
was significantly faster in both conditions 21 days after LHTL (4.5 ± 5.0 vs. 6.2 ± 6.4%
for NH and HH), and no difference between conditions was found at any time.
Conclusion: Increases in VO2max and performance enhancement were similar between
NH and HH conditions.
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INTRODUCTION
Endurance athletes commonly use altitude training camps
with several hypoxic methods to achieve maximal sea-level
performance enhancement (Millet et al., 2010). The “Live
High—Train Low” (LHTL) method, where athletes live and
sleep at altitudes between 2200 and 2500m and train under
1200m (Levine and Stray-Gundersen, 1997; Chapman, 2013), is
recognized as an effectivemethod that can improves performance
in athletes, despite a large inter-subject variability in response
(Lundby et al., 2012). More than 15 years of research have
revealed that LHTL is an effective training method to enhance
sea-level performance in endurance athletes, and it provided
1–3% additional benefit compared with similar normoxic
training, although not confirmed by all studies (Siebenmann
et al., 2012). These altitude-training camps are conducted under
“real” [i.e., hypobaric hypoxia, HH (Stray-Gundersen and Levine,
2008; Chapman et al., 2014; Saugy et al., 2014)] or simulated
altitudes [i.e., normobaric hypoxia, NH (Dehnert et al., 2002;
Clark et al., 2009; Garvican et al., 2011; Schmitt and Millet,
2012)]. Emerging evidence suggests different physiological
responses between these two types of hypoxia (Millet et al., 2012),
and it is now admitted that they cannot be used interchangeably
(Fulco et al., 2011; Saugy et al., 2014; Coppel et al., 2015;
Dipasquale et al., 2015). Short-term exposure in HH seems to
induce greater levels of hypoxemia, when compared to NH
(Savourey et al., 2003). Likewise, reduced ventilatory responses
(Loeppky et al., 1997; Faiss et al., 2013), but higher oxidative
stress, combined with impaired nitric oxide bioavailability (Faiss
et al., 2013) were reported in HH. Regarding all these differences,
pre-acclimatization effectiveness (Fulco et al., 2013) and acute
mountain sickness (AMS) scoring (Dipasquale et al., 2015) are
logically higher in HH.
Sea-level performance improvement following LHTL may
also be different between NH and HH (Bonetti and Hopkins,
2009). Most LHTL studies in HH conditions have reported
performance or hematological improvements (Wehrlin et al.,
2006; Bonetti and Hopkins, 2009; Chapman et al., 2014; Saugy
et al., 2014; Garvican-Lewis et al., 2015), and positive outcomes
have been less frequent in NH conditions (Robach et al., 2006b;
Bonetti and Hopkins, 2009; Clark et al., 2009; Robertson et al.,
2010b), when compared with control (i.e., sea-level) group.
However, there is not a sufficient body of knowledge to confirm
whether NH or HH induces better performance enhancement
after LHTL training camps. It is difficult to compare results
from studies with different parameters, such as different hypoxic
doses, training loads, temperatures and statistical analyses
(Millet et al., 2012; Coppel et al., 2015). There are not any
crossover experimental designs to reduce the influence of the
confounding factors that influence post-altitude responses and
directly compare altitude-induced adaptations and performance
changes after LHTL in NH and HH conditions in the same
subjects. Athletes and coaches generally consider both hypoxic
conditions similar, and it is important to clarify within practical
and ecological conditions whether these two types of LHTL
training camps may be used interchangeably. Consequently,
we designed a crossover study to assess physiological and
performance responses in trained athletes during and after
LHTL camps matched in the inspired pressure of oxygen
(PiO2) in NH or HH conditions. The first phase of the
crossover was published previously (Saugy et al., 2014), and
results demonstrated better performance enhancement after
the altitude training camp conducted under HH conditions.
Groups in the present study were crossed to complete the
crossover design and reduce an eventual group effect. We
hypothesized that the LHTL intervention conducted under HH
conditions would produce better performance improvement
and greater physiological adaptations than under NH, which is
consistent with the results of the first phase of the crossover.
METHODS
Subjects
Twenty-four well-trained male triathletes participated in the
first phase of this study, and 21 male triathletes participated
in the second phase. We pooled data across phases to obtain
a crossover analysis of 16 subjects who were included in both
conditions (n = 10 in 2013 and n = 6 in 2014 for NH
condition, and n = 6 in 2013 and n = 10 in 2014 for HH
condition). The main characteristics of all subjects in the analysis
are presented as means ± standard deviation: age 24 ± 4 years,
body height 179 ± 5 cm, body weight 70 ± 5 kg, BMI 21.8 ±
1.7 kg.m2, VO2max 66.3 ± 7.5mL.kg
−1.min−1, and Pmax 380
± 48 w. Subjects were included in the NH and HH group in
the first phase and switched to the other hypoxia type for the
second phase. The washout period between two phases was 1
year. The following inclusion criteria for participation and data
analysis were used: (1) a minimum of 5 years of endurance
training and frequent participation in endurance competitions;
(2) initial ferritin levels >30µg/l; (3) sufficient training loads
during the lead-in period; and (4) participation in both parts
of the study (i.e., NH and HH altitude camps). All athletes
provided written informed consent to participate in the study.
The local ethical committees approved the study (Commission
Cantonale Valaisanne d’Ethique Médicale, CCVEM; Agreement
051/09 and French National Conference of Research Ethics
Committees; N◦CPP EST I: 2014/33; Dijon, France), which
corresponded to the two training locations. All experimental
procedures conformed to the standards set by the Declaration of
Helsinki.
Study Design
This study includes the first phase of a crossover design published
previously (Saugy et al., 2014). Therefore, values presented here
are means of the two phases (i.e., 2013 and 2014) of the crossover
study unless specified, and more precise details are provided in
the statistics section. Many methodological details are reported
elsewhere (Saugy et al., 2014), but these details are also outlined
here for the reader’s convenience. The experimental design was
identical to the first phase of the crossover and consisted of
a 33-week period divided into four different phases: (1) 24
weeks of training load quantification at sea level; (2) a 3-week
lead-in period also at sea level, where the training loads were
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quantified, and the training sessions were supervised; (3) an 18-
day LHTL training camp under NH or HH conditions; and (4)
a 3-week post-altitude period at sea level where the training
sessions were also supervised and loads quantified (see Figure 1).
The two phases were performed exactly during the same period
of the competitive season (July) for the 2 consecutive years,
with athletes training in the same club under the supervision
of the same coaches. Subjects were assigned to the opposite
condition (NH or HH) of the condition they underwent during
first phase of the study (i.e., in 2013). They were initially matched
based on VO2max values that were measured during the Pre-
test of the 2013 study. Both groups lived at an altitude of
2250m under simulated (NH) or real (HH) hypoxic conditions.
All subjects trained at an altitude between 1100 and 1200
m. Subjects performed several physiological tests in a well-
ventilated laboratory (Prémanon,France, 1150m) before (Pre-)
and immediately after (Post-1) the LHTL camp. Measurements
included blood samples, anthropometric measurements, and
maximal incremental tests on a cycle ergometer (VO2max). The
Pre- and Post-1 tests were performed in the same order at the
same time of day with the same materials for both phases of the
crossover study. Subjects performed five 3-km running tests at
the following times: prior to lead-in, before LHTL (Pre-), 1 day
after LHTL (Post-1), 7 days after LHTL (Post-7), and 21 days after
LHTL (Post-21), in exactly the same manner for 2013 and 2014.
All 3-km running tests were performed near sea level (between
100 and 390m).
Hypoxic Exposure
Subjects were exposed to a normobaric hypoxia equivalent to
2250m during NH conditions, which was obtained by extracting
oxygen (i.e., oxygen filtration) from ambient air in hypoxic
chambers [inspired oxygen pressure (PiO2) 111.9 ± 0.6mmHg;
inspired oxygen fraction (FiO2) 18.05 ± 0.03%; Barometric
pressure (BP) 666.6 ± 3.6mmHg]. The gas composition in each
hypoxic chamber was continuously monitored using oxygen
and carbon dioxide analyzers (FIELDBROOK Ltd., London,
UK) connected to a central station under the control of an
independent and specialized physiologist. The hypoxic chambers
were ofmedium size (15± 1m2) and equippedwith conventional
beds. Two subjects were in each room, and they primarily spent
their time sleeping or resting between training sessions. Subjects
in NH conditions left chambers 5–6 times daily on average to
eat and train. Daily hypoxic dose in NH was 12.7 ± 0.5 h for a
total hypoxic exposure of 229.2 ± 5.9 h. The HH group lived in
Fiescheralp, Switzerland (2250m, PiO2 111.6 ± 0.6mmHg; FiO2
20.9 ± 0.0%; BP 580.2 ± 2.9mmHg) and traveled twice daily to
the valley (altitude <1200m) via cable car for training. The daily
hypoxic dose in HH was 17.1± 1.7 h for a total hypoxic exposure
of 309.9 ± 4.1 h. The hypoxia exposure was monitored daily and
recorded manually for both conditions.
Measurements
Training Loads
Training consisted of swimming, cycling and running. Two
experienced certified coaches supervised and advised athletes
during each training session during camps, and intensity
and volume were matched for both groups. Training load
quantification was performed using “Objective Load Scale”
(ECOs; Cejuela Anta and Esteve-Lanao, 2011), which was
specially developed for training quantification in triathlons.
Briefly, the ECOs were calculated by multiplying the total
duration of a training session (in minutes) with a scoring value
between 1 and 50, depending on the heart rate-based training
zone (1–8) and by a factor of 1.0, 0.75, or 0.5 for running,
swimming, or biking, respectively. Daily and weekly training
loads (ECOs) of each subject were quantified based on each
subject’s physical characteristics and training program intensity.
Running and Maximal Oxygen Uptake
Running performance was evaluated using 3-km running tests
that were completed on a 400-m outdoor synthetic track near
FIGURE 1 | Overview of the whole protocol conducted in a crossover design in 2 consecutive years. In horizontal axis the protocol duration of each part in
weeks (W) and in vertical axis the testing altitude, including: the 6 months before the lead-in period where the training loads were assessed, the lead-in, the LHTL
camp, and the lead-out period. With: 3-km test = the 3-km running tests on the track near sea level made on Pre-, Post-1, Post-7, and Post-21; LHTL = Live High
Train Low training camp for normobaric hypoxia (NH) and hypobaric hypoxia (HH). The two dark gray slots before and after the LHTL period correspond to the 2 days
of Pre- and Post-tests (i.e., Pre1, Pre2 and Post1, Post2, respectively) at 1150m.
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sea level. Starts were given individually in a time-trial mode
(i.e., 30 s between each subjects) to avoid any group or pacing
influences. VO2max was tested before and after LHTL (i.e., at Pre-
1 or Pre-2 and Post-1, see Figure 1) using an incremental cycling
performance test. Subjects were tested on their own bicycles,
which were linked to a computerized ergometer system (Cyclus
2 R©, RBM elektronik automation GmbH, Leipzig, Germany).
Workload was increased by 30W.min−1 after a 5-min warm-
up period at a workload of 90W until voluntary exhaustion
was reached. Subjects were strongly encouraged to perform
until they reached maximal exhaustion. They wore a nose
clip and a mouthpiece for breath collection. Oxygen (O2) and
carbon dioxide (CO2) levels were continuously measured and
monitored as breath-by-breath values in expired gas (Ultima
Cardio 2 gas exchange analysis system, MGC Diagnostics with
Breezesuite software, Saint Paul, MN, USA). The flow meter
and gas analyzer were calibrated prior to each test. VO2max
was determined as the highest 30 s average value and based on
the standard criteria of maximal exhaustion (VO2 plateau, RER
>1.1 and incapacity to maintain the exercise load). Maximal
power output (Pmax) was considered as the load of the last stage
completed.
Blood Samples
Blood samples were taken from the antecubital vein
(3 × 4.9mL EDTA tube R©, Sarstedt, Nümbrecht, Germany)
either immediately after waking up or before breakfast, twice
during each study phase on the first morning during the Pre-
and Post-tests (i.e., before and after LHTL, see Figure 1).
Blood analyses were conducted using an XT-2000i analyzer R©
(Sysmex Europe, Norderstedt, Germany) in a Lausanne
WADA (World Anti-Doping Agency) accredited laboratory
(Lamon et al., 2010). All samples were analyzed in duplicate,
and mean values were used for the study. The following
hematological parameters were quantified: red blood cells
(RBCs), hemoglobin (Hb), hematocrit (Hct), mean cell volume
(MCV), mean cell hemoglobin (MCH), mean cell hemoglobin
concentration (MCHC), reticulocyte percentage (RET%), and
absolute number of reticulocytes (RET#). Regular quality
control procedures were applied as required by the standards of
WADA-accredited laboratories, and the coefficient of variations
(CV) was within the CV limits accepted by the manufacturer
for the instrument. Plasma EPO was quantified using an ELISA
kit R© (Stemcell Technologies, Grenoble, France), and the lower
limit of quantification was measured at 1.6mU/mL. Baseline
ferritin was quantified using standard laboratory procedures
(Dimension EXL, Siemens Healthcare Diagnostics SA, Zürich,
Switzerland) to evaluate subject’s iron stores. All athletes
were tested for doping by the accredited laboratory according
to the biological passport standards to avoid performance
enhancement via doping. Determined CVs were always
below 15%.
Night Assessment
SpO2 and HR were recorded nightly from Pre-1 to Post-2 at
0.25Hz using a wrist oximeter connected to a finger sensor
(Wristox 3150 R© with 8000SM-WO Sensor, Nonin, Plymouth,
MN). The oxygen desaturation index (ODI 3%; i.e., the number
of times per hour of sleep that the blood’s oxygen level
drops by 3% or more) has been calculated throughout the
periods.
Data Analysis and Statistics
Subjects’ data were pooled for each condition from both phases
of the study as follows: the NH condition values considered
were the pooled values from the NH subjects in 2013 (n =
10) and the NH subjects in 2014 (n = 6); the same subjects
were considered for the HH condition but reversed (n = 6
in 2013 and n = 10 in 2014; i.e., n = 16 for the whole
analysis). Data are reported as means and standard deviations
of the 16 subjects considered for the crossover analysis. Data
were tested for equality of variance (Fisher–Snedecor F-test) and
normality (Shapiro–Wilk test). When both conditions were met,
a two-way ANOVA was performed for repeated measures for
each hypoxia condition (NH and HH). To determine the time
effects for variables measured on several occasions during camps,
pairwise multiple comparison procedures was used (Holm–
Sidak method, applied to the SpO2, HR, and training loads).
NH and HH were subsequently compared across time (Pre-,
Post-1, Post-7, and Post-21) using a two-way ANOVA. When
equality of variance or normality was not satisfied (differences
in blood parameters tests from Pre- to Post-1 conditions),
variables were analyzed for each condition using a Friedman
test for repeated measures. To determine time effects, pairwise
multiple comparison procedures was used (Bonferroni test).
Differences in percentage changes between conditions were
tested using a Wilcoxon signed rank sum test (applied to changes
in performance and blood parameters). The statistical power of
the performed tests concerning the 3000m performance with
alpha = 0.05 was, for the time effect of 1.000, and for the group
effect of 0.469. Differences between NH and HH condition at
baseline (Pre-) were tested using a Mann-Whitney rank sum
test (applied to incremental cycling test parameters and baseline
blood sample parameters). Null hypotheses were rejected at P <
0.05. All analyses were completed using Sigmaplot 11.0 software
(Systat Software, San Jose, CA).
RESULTS
Hypoxic Doses, PiO2, Night Peripheral
Oxygen Saturation, and Heart Rate
Daily hypoxic dose (12.7 ± 0.5 vs. 17.1 ± 1.7 h, P < 0.001) and
total hypoxic exposure (229.2± 5.9 vs. 309.9± 4.1 h, P < 0.001)
were lower in NH than in HH. The average PiO2 values were not
different between conditions (111.9± 0.6 vs. 111.6± 0.6mmHg,
for NH and HH). The nightly average of HR was higher for
NH than for HH (51 ± 1 vs. 48 ± 2 bpm for NH and HH,
P < 0.001), and these values stayed higher when returning to
1200m in Prémanon during the two nights of post-test (51 ±
2 vs. 46 ± 2 bpm, for NH and HH, P < 0.001). Nightly SpO2
values were similar between two groups during the control nights
(i.e., the two nights at 1150m before LHTL camps, Pre-1 and
Pre-2), but values were higher in NH than in HH during the
entire camp (D1–D18; 92.4 ± 1.2 vs. 91.3 ± 1.0%, for NH and
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FIGURE 2 | Mean values of night oxygen pulse saturation (SpO2) for the crossover data. Data are presented in mean ± standard error. Pre1-Pre2:
measurements before the camps (1150m, Prémanon, France); D01–D18: measurement during the camps (NH: hypoxic room in Prémanon, France; HH: Fiescheralp,
Switzerland); Post1-Post2: measurements after the camps (1150 m, Prémanon, France). #P < 0.05, ###P < 0.001 for differences between conditions.
HH, P < 0.001). These values remained higher (P < 0.05)
during the two nights at Post-1 (94.4 ± 0.9 vs. 93.6 ± 0.9%, for
NH and HH, P < 0.05). All values are presented in Figure 2.
In addition, the ODI 3% was significantly lower for NH than
HH throughout the hypoxic nights (9.9 ± 1.6 vs. 15.1 ± 3.5,
P < 0.001).
Training Loads
No difference was found in daily training loads during the
lead-in (3 weeks prior LHTL camps; 79.8 ± 22.7 vs. 87.4
± 23.1 ECOs) or the lead-out (3 weeks following the LHTL
camps; 164.4 ± 20.2 vs. 173.9 ± 24.1 ECOs; see Figure 1)
periods between NH and HH, respectively. No difference was
found in daily training loads (226.7 ± 56.5 vs. 214.5 ±
56.4 ECOs for NH and HH groups) between the two groups
during the 18-days LHTL camps in both conditions of the
crossover. Finally, weekly training loads monitored during the
24 weeks prior to the study were not different between groups
(979 ± 207 vs. 1135 ± 98 ECOs for NH and HH group,
respectively). Daily training loads during the LHTL in phase 2
were reduced compared to phase 1 (232.2 ± 27.2 vs. 220.3 ±
31.4 for NH and 217.3 ± 48.1 vs. 211.4 ± 21.0 ECOs for HH,
P < 0.05).
3-km Performance Test
The 3-km performance was significantly increased to a larger
extent in the HH group than in the NH group at Post-21 in the
first phase of the study (−1.2± 2.9 vs. −3.2± 3.8%, for NH and
HH, P < 0.05). Performance in the second phase (i.e., 2014)
increased from Pre- to Post-1 (−3.3 ± 2.0 vs. −3.9 ± 2.9%, for
NH and HH, P < 0.01), Post-7 (−2.7 ± 3.1 vs. −2.6 ± 3.6%,
for NH and HH, P < 0.05), and Post-21 (−8.4 ± 4.1 vs.
−9.1± 6.1%, for NH and HH, P < 0.01). Performance increased
from Post-1 and Post-7 to Post-21 for both conditions. However,
no difference was noted between NH and HH groups at any
time. The crossover demonstrated that performance increased
from Pre- to Post-1 (–1.92%, P < 0.05) and Post-7 (–2.44%,
P < 0.05) for HH but not in NH (–0.97 and -2.27% from
Pre- to Post-1 and Post-7, respectively, ns). And it increased
from Pre- to Post-21 (P < 0.001), Post-1 to Post-21 (P <
0.001), and Post-7 to Post-21 (P < 0.001) for both conditions.
However, no difference was noted between conditions at any
time (Figure 3). We found important inter-individual differences
between both conditions, i.e., during 2 successive years. For
example subject n◦1 decreased his performance time at Post-
21 by -3.6% in NH vs. -7.4% in HH. Subject n◦6 increased his
performance time at Post-21 by 1.9% in NH and decreased it by
-12.1% in HH.
Maximal Test on Cycle Ergometer
Subjects increased their power output and maximal oxygen
uptake values immediately after altitude training camps in both
NH and HH, but without any difference between conditions.
Table 1 presents all values. Ventilation and heart rate at the
submaximal work rate of 190± 24W corresponding to 50% PPO
pre- values have beenmeasured. HR decreased to the same extent
from Pre- to Post-1 (-6 ± 3 vs. −6 ± 2 bpm) and ventilation did
not change significantly (2.5± 2.2 vs.−1.7±7.9 L.min−1) in NH
vs. HH, respectively.
Hematological Parameters
EPO values decreased significantly to the same extent from Pre-
to Post-1 in both conditions (-30 ± 25 and -36 ± 21% for NH
and HH, P < 0.001). No significant changes were observed in
the other parameters. Table 2 presents all values.
Frontiers in Physiology | www.frontiersin.org 5 April 2016 | Volume 7 | Article 138
Saugy et al. LHTL Normobaric vs. Hypobaric Hypoxia
FIGURE 3 | Relative change in 3-km run time from Pre- to Post-1, Post-7, and Post-21 as determined on a running track near sea level for the
normobaric hypoxia (NH) and hypobaric hypoxia (HH) conditions (in %) for the crossover (n = 16). Data are mean ± standard error *P < 0.05 and
***P < 0.001 for differences with Pre-; $$$P < 0.001 for differences with Post-1; †††P < 0.001 for differences with Post-7.
TABLE 1 | Main parameters measured during the incremental test on
ergocycle for normobaric hypoxia (NH) and hypobaric hypoxia (HH) group
before (Pre-) and after (Post-) the camps.
Pre- Post- Delta %
VO2max [ml.O2.kg.min
−1 ] NH 65.2±6.3 68.3±5.0*** 4.9± 5.6
HH 66.7±8.5 68.8±2.4** 3.2± 5.1
HRmax [bpm.min−1 ] NH 191±8 191±6 0.4± 2.2
HH 190±7 189±6 −0.5± 1.7
Pmax [W] NH 362±45 385±33*** 7.1± 6.6
HH 397±46 411±39*** 4.9± 5.1
VEmax [l.min−1 ] NH 180.1±17.4 185.4±15.1 3.6± 10.5
HH 192.3±31.7 195.2±21.7 2.3± 7.7
Physiological parameters during the incremental test on ergocycle; VO2max , maximal
oxygen uptake; HRmax , maximal heart rate; Pmax, maximal power output; VEmax, maximal
ventilation. Data are mean ± SD; **P < 0.01 and ***P < 0.001 for differences between
Pre- and Post-.
DISCUSSION
This study is the first crossover study to compare physiological
and performance responses during and after an 18-days LHTL
altitude camp conducted in NH or HH conditions. The crossover
design incontestably increased the statistical power of the present
analysis compared with the first phase of this study (Saugy et al.,
2014). Lower peripheral oxygen saturation levels during the night
and longer hypoxic exposure were noted in HH than in NH.
However, no differences in blood parameters, maximal power
output or VO2max were observed between hypoxic conditions.
Both conditions directly induced performance enhancement 7 or
21 days after the camps. However, no differences were observed
between NH and HH in sea level performances.
The second phase (i.e., 2014) and crossover 3-km running
performances were not different between conditions at any
TABLE 2 | Main parameters measured with blood analyses for normobaric
hypoxia (NH) and hypobaric hypoxia (HH) group before (Pre-) and after
(Post-) the camps.
Pre- Post- Delta %
EPO [mU/mL] NH 5.12± 2.57 3.08± 1.55*** −33.6±27.3
HH 4.48± 1.45 3.02± 0.71*** −35.7± 19.7
RBC [u/µl] NH 5.21± 0.49 5.29± 0.46 1.7± 7.3
HH 5.24± 0.44 5.29± 0.38 1.1± 4.6
Hb [g/dl] NH 15.38± 1.23 15.99± 1.05 4.3± 6.7
HH 15.44± 1.08 15.75± 1.01 2.4± 5.1
Hct [%] NH 45.52± 3.31 46.70± 3.10 2.9± 7.1
HH 45.51± 3.16 46.44± 2.59 2.5± 3.7
MCV [fl] NH 87.56± 4.10 88.53± 3.48 1.15± 1.3
HH 87.19± 3.46 87.96± 3.30 0.9± 1.4
MCH [pg] NH 29.56± 1.02 30.30± 1.22 2.5± 1.8
HH 29.50± 1.12 29.84± 1.26 1.2± 1.8
MCHC [g/dl] NH 33.78± 0.81 34.25± 0.92 1.4± 1.7
HH 33.83± 0.85 33.92± 0.91 0.3± 2.1
RET [%] NH 1.14± 0.53 1.13± 0.27 6.3± 31.1
HH 1.09± 0.28 1.09± 0.36 3.8± 31.8
Blood and hemoglobin parameters; EPO, erythropoietin; RBC, red blood cells; Hb,
hemoglobin; Htc, hematocrit; MCV, mean cell volume; MCH, mean cell hemoglobin;
MCHC, mean cell hemoglobin concentration; RET, reticulocytes. Data are mean ± SD;
***P < 0.001 for differences between Pre- and Post-.
measurement point (Figure 3), which is unlike the first phase of
the study. Both conditions induced performance enhancements
Post-1, Post-7, and Post-21 in 2014 and at Post-21 when
considering the crossover. VO2max and performance increased
to the same extent for NH and HH conditions. So the
VO2max increase itself could explain at least partly the enhanced
performance. Moreover, there is currently a large debate about
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running economy and efficiency when returning from altitude
camps (Schmitt et al., 2006; Lundby et al., 2007; Chapman,
2013). In the present study VO2 and ventilation were unchanged
while HR decreased to the same extent during a submaximal
cycling test in both groups. These later results show that cycling
efficiency was not modified. It is therefore likely that running
economy did not change significantly and did not influence the
running performance enhancement. This evolution is consistent
with the established insight for the development of performance
after altitude training camps described by Sinex et al. (Sinex
and Chapman, 2015) and drawn from Millet et al. (2010). These
studies have demonstrated initial improvements in performance
(days 1–7) and a higher plateau in performance (days 18–20 or
more). The result that improvements were significant for only
HH at Post-1 and Post-7 in the crossover was clearly influenced
byNHdata of 2013. A group effect was observed in the first phase,
and NH subjects in 2013 did not assimilate the combination of
training load and hypoxic dose as well as the other group. The
training content and load were strictly similar between the two
groups during each phase but were adjusted from phase 1 to
phase 2 by coaches (probably from their experience of phase 1).
The main change consisted in a reduced training load in phase
2 (232.2 ± 27.2 vs. 220.3 ± 31.4 for NH and 217.3 ± 48.1 vs.
211.4± 21.0 ECOs for HH, in phase 1 vs. phase 2) and a different
periodization. Of interest is that a similar training adjustment
has been performed between successive studies conducted in a
chronological order at the same location; i.e., with elite Nordic
skiers (Robach et al., 2006a), swimmers (Robach et al., 2006b),
and distance runners (Brugniaux et al., 2006). The crossover
design tone down this tendency, but it highlights the considerable
importance of inter-individual variations in responses to altitude
training (Friedmann et al., 2005; Garvican et al., 2010; Chapman,
2013; Sinex and Chapman, 2015). Of interest is the observed
intra-individual variability between successive years, in line with
a previous case study (Garvican et al., 2007). This inter- or
intra-subjects variability between the two phases raises questions
about the physiological basis of highly variables findings from
previous published LHTL studies (Pialoux et al., 2009; Robertson
et al., 2010a; Nordsborg et al., 2012; Robach et al., 2012;
Siebenmann et al., 2012; Garvican-Lewis et al., 2013). With
small effects and sample sizes, added to the large among of
confounding factors (i.e., training loads, subjects training level,
food supplies, sleep. . . ), the probability of type 2 errors has been
often under-considered.
The daily exposures are consistent with previous studies in
normobaric or hypobaric hypoxia with 8–12 h.d−1 (Roberts et al.,
2003; Saunders et al., 2004) and 18 h.d−1 (Levine and Stray-
Gundersen, 1997; Wehrlin and Marti, 2006) in NH and HH,
respectively. Night peripheral oxygen saturation was lower for
HH than for NH from the beginning to the end of the camps,
and it remained lower after returning to Prémanon (1150 m)
for the Post-tests (Figure 2). This result confirmed the results
of the first phase of the crossover, and it is consistent with
previous studies (Savourey et al., 2003, 2007; Self et al., 2011)
using short exposures and higher altitudes (<1 h, 4500–7620
m). No difference was reported in longer exposure (up to 24 h,
from 3000 to 4564 m) studies (Roach et al., 1996; Loeppky
et al., 2005; Miyagawa et al., 2011; Faiss et al., 2013). However,
the hypoxic exposure was always shorter than in the present
study. To our knowledge, no study has directly compared NH
and HH conditions in LHTL camps using a crossover design.
Potential mechanisms underlying this difference in the nocturnal
SpO2 found in the present study were reported previously (Saugy
et al., 2014). Briefly, a stronger pulmonary vasoconstriction in
HH, which was induced by the modified fluid circulation and
trans-alveoli-capillary membrane flux under the influence of
barometric pressure, may lead to decreased pressure gradient and
oxygen diffusion (Levine et al., 1988; Loeppky et al., 2005; Millet
et al., 2012). In addition, the ODI 3%, a reliable indicator of
apnea/hypopneas index was calculated throughout all nights and
indicated larger sleep disordered breathing in HH than NH. This
is in line with previous results from Heinzer et al. (2013) who
has reported more hypopneas with polysomnography analyses
in HH compared to NH. However, the present difference in
ODI 3% seems not clinically relevant (much lower than reported
values in clinical groups) for inducing difference in performance
enhancement between conditions. Moreover, Goodall et al.
(2014) recently found that the integrity of the corticospinal
system is modified after 2 weeks at 5260 m, which potentially
reduces fatigue level observed in acute hypoxia and might be a
contributor to increased performance following acclimatization.
Moreover, adaptive changes have been observed after 3 h of
NH exposure (Rupp et al., 2012). Thus, it seems that a time-
dependent effect on the central nervous system exists. These
central nervous system adaptations are likely influencing the
observed changes in performance. However, these mechanisms
have not been investigated in the present study conducted under
lower altitudes.
Differences in daily and total hypoxic exposures were found
between conditions (13 vs. 17 h.d−1 and 230 vs. 310 h for NH
and HH), but our aim was to compare the two LHTL camps
in “real conditions” in ecological ways. Moreover, this hypoxic
doses difference is not the main factor for the SpO2 difference
between NH and HH since SpO2 was lower for HH from the first
night of exposure and remained stable throughout the camps (see
Figure 2).
Hematological parameters evolved to the same extent in
both conditions, which is consistent with recent studies using
natural (Garvican et al., 2012; Garvican-Lewis et al., 2013, 2015;
Saugy et al., 2014) or simulated altitudes (Wehrlin et al., 2006;
Gore et al., 2013; Saugy et al., 2014) in LHTL protocols, but
none of these studies have directly compared NH and HH.
Interestingly, most of the studies on “altitude acclimatization”
(e.g., conducted with untrained lowlanders) failed to demonstrate
altered erythrocyte volume for up to 3 weeks below 4000m
(Sawka et al., 2000). These authors reported that “physical
activity modulates the erythrocyte volume expansion during
altitude acclimatization” and that elite athletes engaged in aerobic
training, despite a large inter-individual variability, might have
larger benefits from the same hypoxic dose, due to genetically
inherited factors that may modulate the hypoxic ventilatory
drive, Hb P50, or erythropoietin responsiveness to hypoxia.
Most of these points remain unresolved and were beyond the
scope of the present study. Nevertheless, the LHTL camps in
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NH or HH did not affect hematological parameters, except
serum EPO concentrations (Table 2). However, the higher the
Hbmass value at the start of the hypoxic exposure, the lower
the Hbmass increase (Robach and Lundby, 2012). This result is
consistent with previous studies from Dehnert et al. (2002) and
Robach et al. (2006b), who have observed no changes in primary
hematological parameters. EPO concentrations significantly fell
when the subjects returned to 1150m for the Post-tests, but
this drop was not different between conditions in the crossover,
unlike the first phase of the study. A drop in EPO after return to
normoxia following continuous hypoxic exposure was reported
previously (Milledge and Cotes, 1985; Savourey et al., 1996, 2004;
Risso et al., 2007; MacNutt et al., 2013). The lower serum EPO
concentration found after the camp in the present study may be
explained by the oscillating nature of LHTL, which was suggested
by Garvican et al. (2012), but the underlying mechanisms are
not clear. However, MacNutt et al. (2013) has provided indirect
evidence of neocytoloysis and an assumption of the mechanisms
in a study with mice: a decrease in EPO mRNA within 1 h of
hypoxia cessation combined with neocytolysis, whereby the most
recently formed erythrocytes are targeted for destruction and
phagocytized by macrophages in the spleen.
STRENGTH AND LIMITATIONS
The use of a crossover design increases statistical power, and it is
of great importance because of the large inter-subject variations
due to hypoxia (Coppel et al., 2015). It is even more important
when comparing normobaric and hypobaric hypoxia because
of the slight nature of their physiological differences. However,
considering the statistical power (i.e., 0.469) for the group effect
on the 3000m performances, we cannot exclude the presence
of type-2 error. Thus, there is still a possibility of performance
difference between NH and HH, despite the crossover-designed
protocol. This study is the first crossover study to compare
prolonged altitude training in NH and HH. The present
study compared the physiological and performance differences
between NH and HH during and after a 3-week LHTL conducted
under “real” conditions (i.e., daily exposures based on the
literature and real training sessions supervised by coaches). The
aim of this study was not to test the effectiveness of LHTL training
alternatives. It is likely that the large performance enhancement
following the LHTL period was due to the intensified training
during both LHTL and lead-out periods. The high training loads
during the LHTL camp could be the main stimulus leading
to performance gain during the lead-out period. Given the
increase in training loads and the lack of a control group,
we cannot evaluate whether hypoxic exposure/acclimatization
actually contributed to the performance enhancement.Moreover,
considering the fact that there was no control group, we cannot
rule out that there is a strong placebo effect that would influence
partly the performance enhancement in the athletes. It is a serious
limitation in the present study since we cannot appreciate the
magnitude of this placebo effect and if it was different between
NH and HH conditions. In addition, considering the statistical
power above-mentioned, further studies are needed with larger
sample sizes to completely answer the research question.
Athletes were well trained, and training loads were not
different between conditions. Training loads were quantified
6 months prior the study and supervised during the whole
protocols for both phases of the crossover. The “real life”
parameters of this study induced significant hypoxic dose
differences between conditions. One cannot exclude that the
slight physiological differences found between NH and HH
would also appear with same hypoxic doses. On the other
hand, we have to consider that simulated vs. real altitude might
have produced different results if we had compared them at
equal hypoxemia doses. Since the condition × time interaction
was not significant, one cannot report from a statistical point
of view that a condition was more efficient than the other
one. However, from a practical and coaching point of view,
the 0.95, 0.17, and 0.58% larger performance improvement in
HH compared to NH (from Pre- to Post-1, Post-7, and Post-
21, respectively) are not negligible. Nevertheless, the aim of
the present study was not a true comparison between these
two hypoxic conditions, which would have requires equal
stimulus levels. This crossover study confirmed that NH and
HH involve different physiological adaptations but elicit similar
performance improvements when using LHTLs of the same
duration. The hypoxic dose and/or the altitude level should be
adjusted to individual athlete responses, e.g., the night SpO2,
to achieve the highest performance improvements. Obviously,
the NH condition is more convenient for this purpose. Further
investigations should focus on the individualization of the
training and hypoxic exposure. Nevertheless, it is important to
take into consideration that the group effect from the larger NH
cohort in 2013 could be driving the results. Since the crossover
is not perfectly balanced (with 10 and 6 instead of 8 and 8) the
crossover design could not “cancel” this tendency.
CONCLUSION
The present crossover study provided a further step to compare
normobaric and hypobaric hypoxia. The results confirmed that
NH and HH are definitely not interchangeable when several
physiological responses are considered, as suggested previously
(Fulco et al., 2011; Millet et al., 2012; Saugy et al., 2014; Coppel
et al., 2015). Despite differences in the stimulus that occur when
using these two different methods in real life, we report no
observable differences in responses to NH vs. HH.
However, the hematological responses and performance
improvements post-LHTL were similar. Each hypoxic condition
has advantages and drawbacks from a practical point of view.
The HH condition leads to longer hypoxic doses for a given
training period (i.e., 18 days in this study), which may fit easier
into a complex training plan with elite athletes, but the logistical
constraints, and the cost may be detrimental. In contrast,
NH condition allows athletes and trainers to individualize the
hypoxic stimulus. It may be interesting to adjust the hypoxic dose
by modifying the time spent in the room or the altitude setting
to athletes’ physiological responses and training level. However,
training camps conducted under normobaric hypoxia require
longer periods of time to achieve sufficient hypoxic doses because
of the lower amount of time spent in hypoxia than under HH.
Frontiers in Physiology | www.frontiersin.org 8 April 2016 | Volume 7 | Article 138
Saugy et al. LHTL Normobaric vs. Hypobaric Hypoxia
AUTHOR CONTRIBUTIONS
JS, LS, and GM made substantial contributions to the
conception and design of the work, the acquisition, analysis,
and interpretation of data for the work; they drafted the work
and revising it critically for important intellectual content. AH,
GC, RC, RF, JW, JR, NR made the acquisition, analysis, or
interpretation of data for the work and revising it critically for
important intellectual content. JS, LS, AH, GC, RC, RF, JW,
JR, NR, and GM gave their final approval of the version to be
published and agreement to be accountable for all aspects of
the work in ensuring that questions related to the accuracy or
integrity of any part of the work are appropriately investigated
and resolved.
ACKNOWLEDGMENTS
This study was funded by grants from the Ministère des
Sports, de la Jeunesse, de l’Education Populaire et de la
Vie Associative (MSJEPVA)/Institut National du Sport, de
l’Expertise et de la Performance (INSEP) and from Bundesamt
für Sport (BASPO; Switzerland). The authors thank the
director Vincent Jacquet and the staff of the National Ski-
Nordic Centre (Prémanon, France) as well as the director
Claudio Rossetti and the staff of the Fierendorf center (Fiesch,
Switzerland) for their invaluable assistance and access to facilities.
The authors also thank Mattia Bertschi for the use of the
instrumented t-shirt and Olivier Girard for his help for the
manuscript.
REFERENCES
Bonetti, D. L., and Hopkins, W. G. (2009). Sea-level exercise performance
following adaptation to hypoxia: a meta-analysis. Sports Med. 39, 107–127. doi:
10.2165/00007256-200939020-00002
Brugniaux, J. V., Schmitt, L., Robach, P., Nicolet, G., Fouillot, J. P.,
Moutereau, S., et al. (2006). Eighteen days of “living high, training
low” stimulate erythropoiesis and enhance aerobic performance in elite
middle-distance runners. J. Appl. Physiol. (1985) 100, 203–211. doi:
10.1152/japplphysiol.00808.2005
Cejuela Anta, R., and Esteve-Lanao, J. (2011). Training load quantification in
triathlon. J. Hum. Sport Exerc. 6, 218–232. doi: 10.4100/jhse.2011.62.03
Chapman, R. F. (2013). The individual response to training and competition at
altitude. Br. J. Sports Med. 47(Suppl. 1), i40–i44. doi: 10.1136/bjsports-2013-
092837
Chapman, R. F., Karlsen, T., Resaland, G. K., Ge, R. L., Harber, M. P., Witkowski,
S., et al. (2014). Defining the “dose” of altitude training: how high to live
for optimal sea level performance enhancement. J. Appl. Physiol. (1985) 116,
595–603. doi: 10.1152/japplphysiol.00634.2013
Clark, S. A., Quod, M. J., Clark, M. A., Martin, D. T., Saunders, P. U., and
Gore, C. J. (2009). Time course of haemoglobin mass during 21 days live
high:train low simulated altitude. Eur. J. Appl. Physiol. 106, 399–406. doi:
10.1007/s00421-009-1027-4
Coppel, J., Hennis, P., Gilbert-Kawai, E., and Grocott, M. P. (2015). The
physiological effects of hypobaric hypoxia versus normobaric hypoxia: a
systematic review of crossover trials. Extrem. Physiol. Med. 4, 2. doi:
10.1186/s13728-014-0021-6
Dehnert, C., Hütler, M., Liu, Y., Menold, E., Netzer, C., Schick, R., et al. (2002).
Erythropoiesis and performance after two weeks of living high and training low
in well trained triathletes. Int. J. Sports Med. 23, 561–566. doi: 10.1055/s-2002-
35533
Dipasquale, D.M., Strangman, G. E., Harris, N. S., andMuza, S. R. (2015). Hypoxia,
hypobaria, and exercise duration affect acute mountain sickness. Aerosp. Med.
Hum. Perform. 86, 614–619. doi: 10.3357/AMHP.4266.2015
Faiss, R., Pialoux, V., Sartori, C., Faes, C., Dériaz, O., and Millet, G.
P. (2013). Ventilation, oxidative stress, and nitric oxide in hypobaric
versus normobaric hypoxia. Med. Sci. Sports Exerc. 45, 253–260. doi:
10.1249/MSS.0b013e31826d5aa2
Friedmann, B., Frese, F., Menold, E., Kauper, F., Jost, J., and Bartsch, P.
(2005). Individual variation in the erythropoietic response to altitude
training in elite junior swimmers. Br. J. Sports Med. 39, 148–153. doi:
10.1136/bjsm.2003.011387
Fulco, C. S., Beidleman, B. A., and Muza, S. R. (2013). Effectiveness of
preacclimatization strategies for high-altitude exposure. Exerc. Sport Sci. Rev.
41, 55–63. doi: 10.1097/JES.0b013e31825eaa33
Fulco, C. S., Muza, S. R., Beidleman, B. A., Demes, R., Staab, J. E., Jones, J. E.,
et al. (2011). Effect of repeated normobaric hypoxia exposures during sleep on
acute mountain sickness, exercise performance, and sleep during exposure to
terrestrial altitude.Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R428–R436.
doi: 10.1152/ajpregu.00633.2010
Garvican, L., Martin, D., Quod, M., Stephens, B., Sassi, A., and Gore, C.
(2012). Time course of the hemoglobin mass response to natural altitude
training in elite endurance cyclists. Scand. J. Med. Sci. Sports 22, 95–103. doi:
10.1111/j.1600-0838.2010.01145.x
Garvican, L. A., Martin, D. T., Clark, S. A., Schmidt, W. F., and Gore, C. J. (2007).
Variability of erythropoietin response to sleeping at simulated altitude: a cycling
case study. Int. J. Sports Physiol. Perform. 2, 327–331.
Garvican, L. A., Martin, D. T., McDonald, W., and Gore, C. J. (2010). Seasonal
variation of haemoglobin mass in internationally competitive female road
cyclists. Eur. J. Appl. Physiol. 109, 221–231. doi: 10.1007/s00421-009-1349-2
Garvican, L. A., Pottgiesser, T., Martin, D. T., Schumacher, Y. O., Barras, M., and
Gore, C. J. (2011). The contribution of haemoglobinmass to increases in cycling
performance induced by simulated LHTL. Eur. J. Appl. Physiol. 111, 1089–1101.
doi: 10.1007/s00421-010-1732-z
Garvican-Lewis, L. A., Clark, S. A., Polglaze, T., McFadden, G., and Gore,
C. J. (2013). Ten days of simulated live high:train low altitude training
increases Hbmass in elite water polo players. Br. J. Sports Med. 1, i70–i73. doi:
10.1136/bjsports-2013-092746
Garvican-Lewis, L. A., Halliday, I., Abbiss, C. R., Saunders, P. U., and Gore, C. J.
(2015). Altitude exposure at 1800m increases haemoglobin mass in distance
runners. J. Sports Sci. Med. 14, 413–417.
Goodall, S., Twomey, R., Amann, M., Ross, E. Z., Lovering, A. T., Romer, L. M.,
et al. (2014). AltitudeOmics: exercise-induced supraspinal fatigue is attenuated
in healthy humans after acclimatization to high altitude. Acta Physiol. (Oxf).
210, 875–888. doi: 10.1111/apha.12241
Gore, C. J., Sharpe, K., Garvican-Lewis, L. A., Saunders, P. U., Humberstone, C.
E., Robertson, E. Y., et al. (2013). Altitude training and haemoglobin mass
from the optimised carbon monoxide rebreathing method determined by a
meta-analysis. Br. J. Sports Med. 47(Suppl. 1), i31–i39. doi: 10.1136/bjsports-
2013-092840
Heinzer, R., Saugy, J., Tobback, N., Rupp, T., Haba-Rubio, J., and Millet, G. (2013).
Effects of real vs simulated altitude on sleep and sleep disordered breathing.
Sleep Med. 14(Suppl. 1), e285. doi: 10.1016/j.sleep.2013.11.697
Lamon, S., Robinson, N., and Saugy, M. (2010). Procedures for monitoring
recombinant erythropoietin and analogs in doping. Endocrinol. Metab. Clin.
North Am. 39, 141–154. doi: 10.1016/j.ecl.2009.10.004
Levine, B. D., and Stray-Gundersen, J. (1997). "Living high-training low": effect of
moderate-altitude acclimatization with low-altitude training on performance.
J. Appl. Physiol. (1985) 83, 102–112.
Levine, B. D., Kubo, K., Kobayashi, T., Fukushima, M., Shibamoto, T., and Ueda,
G. (1988). Role of barometric pressure in pulmonary fluid balance and oxygen
transport. J. Appl. Physiol. (1985) 64, 419–428.
Loeppky, J. A., Icenogle, M., Scotto, P., Robergs, R., Hinghofer-Szalkay, H., and
Roach, R. C. (1997). Ventilation during simulated altitude, normobaric hypoxia
and normoxic hypobaria. Respir. Physiol. 107, 231–239. doi: 10.1016/S0034-
5687(97)02523-1
Frontiers in Physiology | www.frontiersin.org 9 April 2016 | Volume 7 | Article 138
Saugy et al. LHTL Normobaric vs. Hypobaric Hypoxia
Loeppky, J. A., Roach, R. C., Maes, D., Hinghofer-Szalkay, H., Roessler, A., Gates,
L., et al. (2005). Role of hypobaria in fluid balance response to hypoxia. High
Alt. Med. Biol. 6, 60–71. doi: 10.1089/ham.2005.6.60
Lundby, C., Calbet, J. A., Sander, M., Van Hall, G., Mazzeo, R. S., Stray-Gundersen,
J., et al. (2007). Exercise economy does not change after acclimatization to
moderate to very high altitude. Scand. J. Med. Sci. Sports 17, 281–291. doi:
10.1111/j.1600-0838.2006.00530.x
Lundby, C., Millet, G. P., Calbet, J. A., Bartsch, P., and Subudhi, A.W. (2012). Does
’altitude training’ increase exercise performance in elite athletes? Br. J. Sports
Med. 46, 792–795. doi: 10.1136/bjsports-2012-091231
MacNutt, M. J., Rupert, J. L., and Sheel, A. W. (2013). Haematological acclimation
and re-acclimation to hypoxia in the mouse. Respir. Physiol. Neurobiol. 189,
153–161. doi: 10.1016/j.resp.2013.07.018
Milledge, J. S., and Cotes, P. M. (1985). Serum erythropoietin in humans at high
altitude and its relation to plasma renin. J. Appl. Physiol. (1985) 59, 360–364.
Millet, G. P., Faiss, R., and Pialoux, V. (2012). Point: hypobaric hypoxia induces
different physiological responses from normobaric hypoxia. J. Appl. Physiol.
(1985) 112, 1783–1784. doi: 10.1152/japplphysiol.00067.2012
Millet, G. P., Roels, B., Schmitt, L., Woorons, X., and Richalet, J. P. (2010).
Combining hypoxic methods for peak performance. Sports Med. 40, 1–25. doi:
10.2165/11317920-000000000-00000
Miyagawa, K., Kamijo, Y., Ikegawa, S., Goto, M., and Nose, H. (2011). Reduced
hyperthermia-induced cutaneous vasodilation and enhanced exercise-induced
plasma water loss at simulated high altitude (3,200 m) in humans. J. Appl.
Physiol. (1985) 110, 157–165. doi: 10.1152/japplphysiol.00950.2010
Nordsborg, N. B., Siebenmann, C., Jacobs, R. A., Rasmussen, P., Diaz, V.,
Robach, P., et al. (2012). Four weeks of normobaric "live high-train low"
do not alter muscular or systemic capacity for maintaining pH and K(+)
homeostasis during intense exercise. J. Appl. Physiol. (1985) 112, 2027–2036.
doi: 10.1152/japplphysiol.01353.2011
Pialoux, V., Mounier, R., Brugniaux, J. V., Rock, E., Mazur, A., Richalet, J.
P., et al. (2009). Thirteen days of “live high-train low” does not affect
prooxidant/antioxidant balance in elite swimmers. Eur. J. Appl. Physiol. 106,
517–524. doi: 10.1007/s00421-009-1046-1
Risso, A., Turello, M., Biffoni, F., and Antonutto, G. (2007). Red blood cell
senescence and neocytolysis in humans after high altitude acclimatization.
Blood Cells Mol. Dis. 38, 83–92. doi: 10.1016/j.bcmd.2006.10.161
Roach, R. C., Loeppky, J. A., and Icenogle, M. V. (1996). Acute mountain sickness:
increased severity during simulated altitude compared with normobaric
hypoxia. J. Appl. Physiol. (1985) 81, 1908–1910.
Robach, P., and Lundby, C. (2012). Is live high-train low altitude training relevant
for elite athletes with already high total hemoglobin mass? Scand. J. Med. Sci.
Sports 22, 303–305. doi: 10.1111/j.1600-0838.2012.01457.x
Robach, P., Schmitt, L., Brugniaux, J. V., Nicolet, G., Duvallet, A., Fouillot, J. P.,
et al. (2006a). Living high-training low: effect on erythropoiesis and maximal
aerobic performance in elite Nordic skiers. Eur. J. Appl. Physiol. 97, 695–705.
doi: 10.1007/s00421-006-0240-7
Robach, P., Schmitt, L., Brugniaux, J. V., Roels, B., Millet, G., Hellard, P.,
et al. (2006b). Living high-training low: effect on erythropoiesis and aerobic
performance in highly-trained swimmers. Eur. J. Appl. Physiol. 96, 423–433.
doi: 10.1007/s00421-005-0089-1
Robach, P., Siebenmann, C., Jacobs, R. A., Rasmussen, P., Nordsborg, N., Pesta,
D., et al. (2012). The role of haemoglobin mass on VO(2)max following
normobaric ’live high-train low’ in endurance-trained athletes. Br. J. Sports
Med. 46, 822–827. doi: 10.1136/bjsports-2012-091078
Roberts, A. D., Clark, S. A., Townsend, N. E., Anderson, M. E., Gore, C. J., and
Hahn, A. G. (2003). Changes in performance, maximal oxygen uptake and
maximal accumulated oxygen deficit after 5, 10 and 15 days of live high:train
low altitude exposure. Eur. J. Appl. Physiol. 88, 390–395. doi: 10.1007/s00421-
002-0720-3
Robertson, E. Y., Saunders, P. U., Pyne, D. B., Aughey, R. J., Anson, J.
M., and Gore, C. J. (2010a). Reproducibility of performance changes to
simulated live high/train low altitude. Med. Sci. Sports Exerc. 42, 394–401. doi:
10.1249/MSS.0b013e3181b34b57
Robertson, E. Y., Saunders, P. U., Pyne, D. B., Gore, C. J., and Anson, J. M.
(2010b). Effectiveness of intermittent training in hypoxia combined with live
high/train low. Eur. J. Appl. Physiol. 110, 379–387. doi: 10.1007/s00421-010-
1516-5
Rupp, T., Jubeau, M., Wuyam, B., Perrey, S., Levy, P., Millet, G. Y., et al. (2012).
Time-dependent effect of acute hypoxia on corticospinal excitability in healthy
humans. J. Neurophysiol. 108, 1270–1277. doi: 10.1152/jn.01162.2011
Saugy, J. J., Schmitt, L., Cejuela, R., Faiss, R., Hauser, A., Wehrlin, J. P., et al.
(2014). Comparison of “Live High-Train Low” in normobaric versus hypobaric
hypoxia. PLoS ONE 9:e114418. doi: 10.1371/journal.pone.0114418
Saunders, P. U., Telford, R. D., Pyne, D. B., Cunningham, R. B., Gore, C. J., Hahn,
A. G., et al. (2004). Improved running economy in elite runners after 20 days of
simulated moderate-altitude exposure. J. Appl. Physiol. (1985) 96, 931–937. doi:
10.1152/japplphysiol.00725.2003
Savourey, G., Garcia, N., Besnard, Y., Guinet, A., Hanniquet, A. M., and Bittel,
J. (1996). Pre-adaptation, adaptation and de-adaptation to high altitude in
humans: cardio-ventilatory and haematological changes. Eur. J. Appl. Physiol.
Occup. Physiol. 73, 529–535. doi: 10.1007/BF00357675
Savourey, G., Launay, J. C., Besnard, Y., Guinet, A., Bourrilhon, C., Cabane, D.,
et al. (2004). Control of erythropoiesis after high altitude acclimatization. Eur.
J. Appl. Physiol. 93, 47–56. doi: 10.1007/s00421-004-1159-5
Savourey, G., Launay, J. C., Besnard, Y., Guinet, A., and Travers, S. (2003). Normo-
and hypobaric hypoxia: are there any physiological differences? Eur. J. Appl.
Physiol. 89, 122–126. doi: 10.1007/s00421-002-0789-8
Savourey, G., Launay, J. C., Besnard, Y., Guinet-Lebreton, A., Alonso, A., Sauvet,
F., et al. (2007). Normo or hypobaric hypoxic tests: propositions for the
determination of the individual susceptibility to altitude illnesses. Eur. J. Appl.
Physiol. 100, 193–205. doi: 10.1007/s00421-007-0417-8
Sawka, M. N., Convertino, V. A., Eichner, E. R., Schnieder, S. M., and Young,
A. J. (2000). Blood volume: importance and adaptations to exercise training,
environmental stresses, and trauma/sickness. Med. Sci. Sports Exerc. 32,
332–348. doi: 10.1097/00005768-200002000-00012
Schmitt, L., and Millet, G. P. (2012). Ineffective normobaric LHTL: room
confinement or inappropriate training intensity? J. Appl. Physiol. (1985) 112,
527. doi: 10.1152/japplphysiol.01431.2011
Schmitt, L., Millet, G., Robach, P., Nicolet, G., Brugniaux, J. V., Fouillot, J. P.,
et al. (2006). Influence of “living high-training low” on aerobic performance
and economy of work in elite athletes. Eur. J. Appl. Physiol. 97, 627–636. doi:
10.1007/s00421-006-0228-3
Self, D. A., Mandella, J. G., Prinzo, O. V., Forster, E. M., and Shaffstall, R. M.
(2011). Physiological equivalence of normobaric and hypobaric exposures of
humans to 25,000 feet (7620 m). Aviat. Space Environ. Med. 82, 97–103. doi:
10.3357/ASEM.2908.2011
Siebenmann, C., Robach, P., Jacobs, R. A., Rasmussen, P., Nordsborg, N., Diaz,
V., et al. (2012). "Live high-train low" using normobaric hypoxia: a double-
blinded, placebo-controlled study. J. Appl. Physiol. (1985) 112, 106–117. doi:
10.1152/japplphysiol.00388.2011
Sinex, J. A., and Chapman, R. F. (2015). Hypoxic training methods for
improving endurance exercise performance. J. Sport Health Sci. 4, 325–332. doi:
10.1016/j.jshs.2015.07.005
Stray-Gundersen, J., and Levine, B. D. (2008). Live high, train low at natural
altitude. Scand. J. Med. Sci. Sports 18(Suppl. 1), 21–28. doi: 10.1111/j.1600-
0838.2008.00829.x
Wehrlin, J. P., and Marti, B. (2006). Live high-train low associated with increased
haemoglobin mass as preparation for the 2003 World Championships in two
native European world class runners. Br. J. Sports Med. 40, e3. discussion e3.
doi: 10.1136/bjsm.2005.019729
Wehrlin, J. P., Zuest, P., Hállen, J., and Marti, B. (2006). Live high-train low for 24
days increases hemoglobinmass and red cell volume in elite endurance athletes.
J. Appl. Physiol. (1985) 100, 1938–1945. doi: 10.1152/japplphysiol.01284.2005
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Saugy, Schmitt, Hauser, Constantin, Cejuela, Faiss, Wehrlin,
Rosset, Robinson and Millet. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 10 April 2016 | Volume 7 | Article 138
